Evropska unija -
slovenščina -
EMA (European Medicines Agency)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sedalin gel
vetoquinol biowet sp -
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
permaway
vetoquinol biowet sp -
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
levetiracetam mylan 1000 mg filmsko obložene tablete
generics (uk) ltd. - levetiracetam - filmsko obložena tableta - levetiracetam 1000 mg / 1 tableta - levetiracetam
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
levetiracetam mylan 500 mg filmsko obložene tablete
generics (uk) ltd. - levetiracetam - filmsko obložena tableta - levetiracetam 500 mg / 1 tableta - levetiracetam
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
levetiracetam mylan 250 mg filmsko obložene tablete
generics (uk) ltd. - levetiracetam - filmsko obložena tableta - levetiracetam 250 mg / 1 tableta - levetiracetam
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
narketan (bioketan)
vetoquinol biowet -
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).